Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone taper for delayed TKA recovery
NCT05113901Phase 4Terminated
- Sponsor
- Rush University Medical Center
- Start
- Mar 2022
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Arthrofibrosis comparing Methylprednisolone taper with Placebo taper (2 arms). Primary endpoint: Range of Motion. Started Mar 2022; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT05113901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05113901.